Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice

Amir Daei Farshchi Adli ¹, Rana Jahanban-Esfahlan ¹, Khaled Seidi ¹, Davoud Farajzadeh ², Ramezan Behzadi ³, Nosratollah Zarghami ^1,4 *

Cited by CrossRef: 3

1- Markowicz J, Wołowiec S, Rode W, Uram Ł. Synthesis and Properties of α-Mangostin and Vadimezan Conjugates with Glucoheptoamidated and Biotinylated 3rd Generation Poly(amidoamine) Dendrimer, and Conjugation Effect on Their Anticancer and Anti-Nematode Activities. Pharmaceutics. 2022;14(3):606 [Crossref]

2- Tong S, Zhao W, Zhao D, Zhang W, Zhang Z. Biomaterials-Mediated Tumor Infarction Therapy. Front Bioeng Biotechnol. 2022;10 [Crossref]

3- Mahmudi H, Adili-Aghdam M, Shahpouri M, Jaymand M, Amoozgar Z, Jahanban-Esfahlan R. Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease. Front Oncol. 2022;12 [Crossref]